Title: Pre-Clinical Imaging Market by Systems and Reagents to 2017
1Pre-Clinical Imaging (In vivo) Market By
Systems and Reagents Micro-PET, Optical Imaging,
Micro-MRI, Micro-SPECT, Micro-Ultrasound,
Micro-CT Multimodality/Hybrid Imaging
Modalities - Competitive Analysis Global
Forecasts to 2017
Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
- Published December 2012
- Single User PDF US 4650
- Corporate User PDF US 7150
2Pre-Clinical Imaging (In vivo) Market By
Systems and Reagents Micro-PET, Optical Imaging,
Micro-MRI, Micro-SPECT, Micro-Ultrasound,
Micro-CT Multimodality/Hybrid Imaging
Modalities - Competitive Analysis Global
Forecasts to 2017
- Pre-clinical imaging technologies are excellent
tools for assessment of anatomical, physiological
and functional parameters at molecular and
cellular levels in the live animal models. It
plays a significant role in the assessment of
specific drug candidate or treatment regime, in
phenotyping and understanding the pathophysiology
of various diseases. - The global pre-clinical imaging (in vivo) market
has witnessed challenging and dynamic market
conditions in terms of government funding/grants
and technological advancements in the last five
years. The overall pre-clinical imaging (in vivo)
market is valued at 790 million in 2012, and is
estimated to grow at an annual growth rate of
14.5 over the next five years. Market displays
growing preference for new technologies such as
hybrid systems PET MRI, SPECT MRI and PET
SPECT CT, for the continuum of advantages
offered by them over traditional standalone
techniques as they enable to overcome limitations
of each technology. Pre-clinical imaging (in
vivo) industry has witnessed myriad technological
advancements over the last two decades and it is
expected that this trend will continue in future
to solve the present challenges and fill the
unmet needs of the market. - Request Sample for this Report _at_
- http//www.reportsnreports.com/contacts/requestsam
ple.aspx?name208975 .
Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
3Pre-Clinical Imaging (In vivo) Market By
Systems and Reagents Micro-PET, Optical Imaging,
Micro-MRI, Micro-SPECT, Micro-Ultrasound,
Micro-CT Multimodality/Hybrid Imaging
Modalities - Competitive Analysis Global
Forecasts to 2017
- Factors such as increasing pre-clinical research
studies, technological advancements, rising
government support in developing markets, growing
use of functional imaging, and increasing number
of pharma companies and research institutions,
are spurring the growth of pre-clinical imaging
market. However, high cost of imaging systems and
technological limitations are restraining the
market growth. Market is facing some major
challenges such as industry consolidation, slow
adoption rate of pre-clinical imaging
technologies by tier I and tier II pharma/biotech
companies and lack of sufficient accessibility of
radiotracers for nuclear imaging. - In 2012, North America is the biggest market,
about 38.2 share of the global pre-clinical
imaging (in vivo) systems and reagents market,
followed by Europe. However, the Asian and Latin
American countries represent the fastest growing
markets due to increasing government support for
research, growing number of research institution
and CROs, and rising industry-academia
partnerships for pre-clinical research. Moreover,
economic slowdown, pricing pressures and high
competition in mature countries will compel the
companies to focus on the Asian market. - Market has opportunity for imaging systems which
will be cost effective with applications in
multiple fields. In addition, unique combinations
of imaging modalities such as MRI and optical
imaging, which will address the challenges
associated with the currently marketed imaging
combinations are expected to have better future
prospects for growth. - Inquire Discount _at_ http//www.reportsnreports.com/
contacts/discount.aspx?name208975 .
Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.